Diazepam discontinuation through agomelatine in schizophrenia with insomnia and depression.
Armando L
AL
Morera-Fumero
Pedro
P
Abreu-Gonzalez
D000081:Acetamides / Q000627:therapeutic use*; D000328:Adult; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy*; D003975:Diazepam / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy*; D012720:Severity of Illness Index; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D016896:Treatment Outcome; D009281:Naphthalenes
D000081:Acetamides; D014151:Anti-Anxiety Agents; D003975:Diazepam; D006993:Hypnotics and Sedatives; C084711:agomelatine; D009281:Naphthalenes